Skip to main content
2026 CRT Conference Main banner

CRT 2026

Power Break Symposium

Session:: Power Break Symposium | The Future of HTN Care Is Now: The Symplicity™ Blood Pressure Procedure [Non-CME] – Sponsored by Medtronic

Discussion

Sunday, March 8, 2026
12:52 PM - 12:59 PM EST
Location: International Ballroom West

    Moderator(s)

  • Eric A. Secemsky, MD, MSc

    Director of Vascular Intervention
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure(s): Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)

    • Panel Discussant(s)

  • Rasha Al-Lamee, MA, MD, PhD

    Interventional Cardiology Consultant
    Imperial College London
    London, England, United Kingdom

    Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Jannsen: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Michael J. Bloch, MD

    Medical Director, Vascular Care
    Renown Institute for Heart and Vascular Health
    reno, Nevada, United States

    Disclosure(s): Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • AN

    Aravinda Nanjundappa, MD, FSCAI

    Director of Peripheral Vascular Interventions, Cardiovascular Division
    Cleveland Clinic , Main Campus
    Pepper pike, Ohio, United States

    Disclosure(s): No financial relationships to disclose

  • Raymond R. Townsend, MD

    Professor
    University of Pennsylvania, Pennsylvania, United States

    Disclosure(s): AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):
Eric A. Secemsky, MD, MSc: Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)
Rasha Al-Lamee, MA, MD, PhD: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Jannsen: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Michael J. Bloch, MD: Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Aravinda Nanjundappa, MD, FSCAI: No financial relationships to disclose
Raymond R. Townsend, MD: AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing)